Roger Aston
Chairman presso RESP HEAL
Patrimonio netto: 114 074 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Brian Leedman | M | - | 11 anni | |
| Sam Wright | M | 46 | 18 anni | |
| Paul Brennan | M | 63 | 2 anni | |
| Nigel Lange | M | - | 4 anni | |
| Jerry Kanellos | M | 61 | 9 anni | |
| Darren M. Keamy | M | - | 19 anni | |
| Tony Keating | M | - | 9 anni | |
| Brenda Mary Shanahan | F | - | 17 anni | |
| Ravi Savarirayan | M | 57 | 7 anni | |
| Richard Mollard | M | - |
Pitney Pharmaceuticals Pty Ltd.
 Pitney Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of PharmAust Ltd., Pitney Pharmaceuticals Pty Ltd. provides medical and pharmaceutical services. The private company is based in Kogarah, Australia. The CEO of the Australian company is Richard Mollard. Pitney Pharmaceuticals was acquired by PharmAust Ltd. on August 13, 2013 for $8.18 million. | - |
| Travis Robins | M | - | - | |
| Steven Lydeamore | M | 56 | 2 anni | |
| Philippe Wolgen | M | 61 | 19 anni | |
| Daniel Pollock | M | 64 | 12 anni | |
| Phillip Hains | M | 64 | 11 anni | |
| David John Williams | M | 70 | 10 anni | |
| David Turner | M | - | 3 anni | |
| Thomas Duthy | M | - | - | |
| Christopher Ntoumenopoulos | M | - | 9 anni | |
| Nicola Farley | F | 45 | 12 anni | |
| Richard L. Faherty | M | 77 |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The private company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | - |
| Reza Moussakhani | M | - | 11 anni | |
| Robert Charles Bishop | M | - | 11 anni | |
| Michael Stein | M | 60 | 4 anni | |
| Lachlan Hay | M | - | 17 anni | |
| Paul Hopper | M | 68 |
Biolife Science Ltd.
 Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The private company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | - |
| Joanne Casey | M | 47 | - | |
| Jamie Joint | F | - | - | |
| Mike Connell | M | - | 3 anni | |
| Al Rey Lunar | M | - | 4 anni | |
| Scott Savage | M | - | 3 anni | |
| Flavio Palumbo | M | 50 | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Nick Falzon | M | - | 4 anni | |
| Craig Bottomley | M | - |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 anni |
| Aaron John Finlay | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 anni |
| Bryant McLarty | M | - | 10 anni | |
| Roger Corbett | M | 81 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| David J. Sparling | M | 52 | 9 anni | |
| Chris Roberts | M | 70 | 5 anni | |
| Ron Best | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 13 anni |
| John Martin | M | 62 | 10 anni | |
| Graeme Roy Kaufman | M | 74 | 6 anni | |
| Stuart Mudge | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| David Parry | M | 70 |
The University of Manchester
| 7 anni |
| Neil M. Frazer | M | 68 | 1 anni | |
| Ian Frank Scholes | M | 69 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 15 anni |
| Bruce Mathieson | M | 80 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 3 anni |
| Yao Lee | M | 54 | 7 anni | |
| Martin Frederick Rogers | M | 43 | - | |
| Daniel Kenny | M | - | 6 anni | |
| John Bird | M | - | - | |
| Angelo Morella | M | - | - | |
| Grant Rawlin | M | - | 14 anni | |
| Peter Anastasiou | M | 63 | 6 anni | |
| Margaret Kay Taylor | F | 64 | - | |
| Udantha Abeyratne | M | - | 5 anni | |
| Martin Cross | M | - | 5 anni | |
| Karl Pechmann | M | - | 3 anni | |
| Elane Zelcer | M | - | 4 anni | |
| Amos Meltzer | M | 58 | - | |
| Peter Vaughan | M | 40 | 5 anni | |
| Thomas Liquard | M | 51 | 2 anni | |
| Beverley June Hughes | F | 74 |
The University of Manchester
| 21 anni |
| David Morris | M | - | - | |
| Scott Richards | M | 60 | 10 anni | |
| Stephen Anastasiou | M | 67 | 11 anni | |
| Jillian McGregor | F | - | - | |
| Dan Peres | M | - | 3 anni | |
| Panos Andreas Loizou | M | 60 |
The University of Manchester
| 7 anni |
| Okechukwu John Mbonu | M | 71 |
The University of Manchester
| 8 anni |
| Ben Herbert | M | 56 | 7 anni | |
| Steven Swinson | M | - |
The University of Manchester
| 4 anni |
| Richard Berman | M | 81 | 1 anni | |
| Robert Johnston | M | - | 6 anni | |
| Philip Powell | M | 65 | 6 anni | |
| Lawrence John Wood | M | 87 | 6 anni | |
| Alan Dunton | M | 70 | 2 anni | |
| Otto Buttula | M | - | 2 anni | |
| Gary Jacob | M | 77 | 2 anni | |
| Geoffrey Norman Vaughan | M | 91 | 15 anni | |
| Stewart Washer | M | 54 | 1 anni | |
| Richard H. Irving | M | - |
The University of Manchester
| 6 anni |
| Andrew Burgess | M | 55 |
Ascent Pharmahealth Pty Ltd.
 Ascent Pharmahealth Pty Ltd. Pharmaceuticals: MajorHealth Technology Ascent Pharmahealth Pty Ltd. manufactures and supplies generic pharmaceuticals. It offers skincare, private prescription medicine, and dermorganics. The company was founded by Dennis Bastas in December 2003 and is headquartered in Australia. | - |
| Simon O'Loughlin | M | 66 | 1 anni | |
| John Chiplin | M | 66 | 3 anni | |
| Wayne Best | M | - | 4 anni | |
| Fung Man Wai | M | 75 |
The University of Manchester
| 4 anni |
| Adam James Sierakowski | M | - | 3 anni | |
| David Franklyn | M | 60 | 4 anni | |
| Tom Milicevic | M | - | 4 anni | |
| Mark Cansdale | M | - | 6 anni | |
| Paul MacLeman | M | 58 | 4 anni | |
| Lawrence Gozlan | M | 45 | 1 anni | |
| Joseph M. Baini | M | 58 | 2 anni | |
| Glen Richards | M | - | 5 anni | |
| Robyn Elliott | M | 63 | 18 anni | |
| Henry Gulev | M | - | 6 anni | |
| Graeme N. Stevens | M | - | 6 anni | |
| Wai Ching Wong | F | 63 |
The University of Manchester
| 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Australia | 90 | 90.91% |
| Regno Unito | 9 | 9.09% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Roger Aston
- Contatti personali
